The journal retracts the article “DNA Based and Stimuli-Responsive Smart Nanocarrier for Diagnosis and Treatment of Cancer: Applications and Challenges” [1], cited above.
Following publication, concerns were brought to the attention of the Editorial Office regarding the relevance of several references presented in this article [1].
In accordance with standard journal procedures, the Editorial Office and Editorial Board conducted an investigation that confirmed the presence of a number of inappropriate citations. Additionally, the investigation identified unacknowledged overlaps with eight other published articles [2,3,4,5,6,7,8,9], without appropriate acknowledgement or citation. Consequently, the Editorial Board has lost confidence in the reliability of the findings and decided to retract this publication [1], as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30) (19 May 2026).
This retraction was approved by the Editor-in-Chief of the journal Cancers.
The authors have been informed of this retraction and have indicated their disagreement with this decision.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
References
- 1.Sabir F., Zeeshan M., Laraib U., Barani M., Rahdar A., Cucchiarini M., Pandey S. RETRACTED: DNA Based and Stimuli-Responsive Smart Nanocarrier for Diagnosis and Treatment of Cancer: Applications and Challenges. Cancers. 2021;13:3396. doi: 10.3390/cancers13143396. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 2.Wu D., Wang L., Li W., Xu X., Jiang W. DNA nanostructure-based drug delivery nanosystems in cancer therapy. Int. J. Pharm. 2017;533:169–178. doi: 10.1016/j.ijpharm.2017.09.032. [DOI] [PubMed] [Google Scholar]
- 3.Mi P. Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics. Theranostics. 2020;10:4557–4588. doi: 10.7150/thno.38069. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Kim T., Nam K., Kim Y.M., Yang K., Roh Y.H. DNA-assisted smart nanocarriers: Progress, challenges, and opportunities. ACS Nano. 2021;15:1942–1951. doi: 10.1021/acsnano.0c08905. [DOI] [PubMed] [Google Scholar]
- 5.Chen H., Liu D., Guo Z. Endogenous Stimuli-responsive Nanocarriers for Drug Delivery. Chem. Lett. 2016;45:242–249. doi: 10.1246/cL.151176. [DOI] [Google Scholar]
- 6.Chi Q., Yang Z., Xu K., Wang CLiang H. DNA Nanostructure as an Efficient Drug Delivery Platform for Immunotherapy. Front. Pharmacol. 2020;10:1585. doi: 10.3389/fphar.2019.01585. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Zhan P., Jiang Q., Wang Z.-G., Li N., Yu H., Ding B. DNA Nanostructure-Based Imaging Probes and Drug Carriers. ChemMedChem. 2014;9:2013–2020. doi: 10.1002/cmdc.201402137. [DOI] [PubMed] [Google Scholar]
- 8.Xu F., Xia Q., Wang P. Rationally Designed DNA Nanostructures for Drug Delivery. Front. Chem. 2020;8:751. doi: 10.3389/fchem.2020.00751. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Bae W., Kocabey S., Liedl T. DNA nanostructures in vitro, in vivo and on membranes. Nano Today. 2019;26:98–107. doi: 10.1016/j.nantod.2019.03.001. [DOI] [Google Scholar]